ACHC, TDW and RMR have been added to the Zacks Rank #5 (Strong Sell) List on March 5, 2025.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q4 2024 Earnings Conference Call February 28, 2025 9:00 AM ET Company Participants Patrick Feeley - Senior Vice President of Investor Relations Christopher Hunter - Chief Executive Officer Heather Dixon - Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners Brian Tanquilut - Jefferies A.J. Rice - UBS Ben Hendrix - RBC Capital Markets John Ransom - Raymond James Matthew Gillmor - KeyBanc Capital Markets Scott Fidel - Stephens Andrew Mok - Barclays Operator Hello, and welcome to the Acadia Healthcare Fourth Quarter 2024 Earnings Conference Call.
ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.
Acadia Healthcare (ACHC) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.85 per share a year ago.
ACHC's fourth-quarter earnings are likely to have benefited from growing patient days and admissions.
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Medical-Hospital industry is likely to benefit from improving financial, operating and staffing stability. Companies like HCA, THC, UHS, ACHC and CYH are well-positioned to gain from these trends.
Acadia Healthcare (ACHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ACHC remains well-poised for growth, attributable to sustained demand for behavioral healthcare services, as well as growth initiatives such as acquisitions, bed additions and joint ventures.
NEW YORK, NY / ACCESSWIRE / December 17, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 16, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Acadia Healthcare Company, Inc. ("Acadia" or "the Company") (NASDAQ:ACHC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company 's securities between February 28, 2020 and September 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 16, 2024.